Wei Geng
Yancheng, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Methotrexate exerts antitumor immune activity and improves the clinical efficacy of immunotherapy in patients with solid tumors.
Journal: Science translational medicine
Published: June 04, 2025
Inflammatory markers correlate with lymphocytes infiltrating and predict immunotherapy prognosis for esophageal cancer.
Journal: Future oncology (London, England)
Published: November 12, 2024
Inhibition of 6-phosphogluconate dehydrogenase suppresses esophageal squamous cell carcinoma growth and enhances the anti-tumor effects of metformin via the AMPK/mTOR pathway.
Journal: Molecular cancer
Published: September 25, 2024
Geriatric Nutritional Risk Index is an effective prognostic predictor for metastatic/recurrent or unresectable esophageal cancer receiving immunotherapy.
Journal: Journal of gastrointestinal oncology
Published: September 23, 2024
Prognostic value of hemoglobin combined with Geriatric Nutritional Risk Index scores in patients undergoing postoperative radiotherapy for esophageal squamous cell carcinoma.
Journal: Future oncology (London, England)
Published: December 06, 2021
Combination of Haemoglobin and Prognostic Nutritional Index Predicts the Prognosis of Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma.
Journal: Cancer management and research
Published: June 10, 2020
Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer.
Journal: Journal of hematology & oncology
Published: March 23, 2020
DNA‑PKcs inhibitor increases the sensitivity of gastric cancer cells to radiotherapy.
Journal: Oncology reports
Published: May 18, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026